Taylor, David

Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study

Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M. J., Erritzoe, D., Kaelen, M., Bloomfield, M., Rickard, J. A., Forbes, B., Feilding, A., et al. (2016) · The Lancet Psychiatry

Psychedelics and Drug StudiesTreatment of Major Depression

Cited by 1,540

Psilocybin with psychological support for treatment-resistant depression: six-month follow-up

Carhart-Harris, R. L., Bolstridge, M., Day, C. M. J., Rucker, J., Watts, R., Erritzoe, D. E., Kaelen, M., Giribaldi, B., Bloomfield, M., Pilling, S., et al. (2018) · Psychopharmacology

Psychedelics and Drug StudiesTreatment of Major Depression

Cited by 970

Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines

Cleare, A., Pariante, C., Young, A., Anderson, I., Christmas, D., Cowen, P., Dickens, C., Ferrier, I., Geddes, J., Gilbody, S., et al. (2015) · Journal of Psychopharmacology

Treatment of Major DepressionMental Health Treatment and Access

Cited by 759

The Maudsley Prescribing Guidelines

Taylor, D., Paton, C., & Kerwin, R. (2007) · CRC Press eBooks

Treatment of Major DepressionSchizophrenia research and treatment

Cited by 366

International trends in clozapine use: a study in 17 countries

Bachmann, C. J., Aagaard, L., Bernardo, M., Brandt, L., Cartabia, M., Clavenna, A., Coma Fusté, A., Furu, K., Garuoliené, K., Hoffmann, F., et al. (2017) · Acta Psychiatrica Scandinavica

Schizophrenia research and treatmentMental Health Treatment and Access

Cited by 314

The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal

Brissos, S., Veguilla, M. R., Taylor, D., & Balanzá-Martinez, V. (2014) · Therapeutic Advances in Psychopharmacology

Schizophrenia research and treatmentHistorical Psychiatry and Medical Practices

Cited by 297

Tapering of SSRI treatment to mitigate withdrawal symptoms

Horowitz, M. A., & Taylor, D. (2019) · The Lancet Psychiatry

Treatment of Major DepressionNeurotransmitter Receptor Influence on Behavior

Cited by 280

Should psychiatrists be more cautious about the long-term prophylactic use of antipsychotics?

Murray, R. M., Quattrone, D., Natesan, S., van Os, J., Nordentoft, M., Howes, O., Di Forti, M., & Taylor, D. (2016) · British Journal of Psychiatry

Schizophrenia research and treatmentMental Health and Psychiatry

Cited by 244

A Method for Tapering Antipsychotic Treatment That May Minimize the Risk of Relapse

Horowitz, M. A., Jauhar, S., Natesan, S., Murray, R. M., & Taylor, D. (2021) · Schizophrenia Bulletin

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 157

Comparative Efficacy and Acceptability of Drug Treatments for Bipolar Depression: A Multiple-Treatments Meta-Analysis

Taylor, D. M., Cornelius, V., Smith, L., & Young, A. H. (2014) · Acta Psychiatrica Scandinavica

Bipolar Disorder and TreatmentTreatment of Major Depression

Cited by 122

Attention-deficit/hyperactivity disorder medication consumption in 64 countries and regions from 2015 to 2019: a longitudinal study

Chan, A. Y. L., Ma, T.-T., Lau, W. C. Y., Ip, P., Coghill, D., Gao, L., Jani, Y. H., Hsia, Y., Wei, L., Taxis, K., et al. (2023) · eClinicalMedicine

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 95

Estimating Risk of Antidepressant Withdrawal from a Review of Published Data

Horowitz, M. A., Framer, A., Hengartner, M. P., Sørensen, A., & Taylor, D. (2023) · CNS Drugs

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 76

Characterisation of nasal devices for delivery of insulin to the brain and evaluation in humans using functional magnetic resonance imaging

Wingrove, J., Swedrowska, M., Scherließ, R., Parry, M., Ramjeeawon, M., Taylor, D., Gauthier, G., Brown, L., Amiel, S., Zelaya, F., et al. (2019) · Journal of Controlled Release

Advanced Drug Delivery SystemsInhalation and Respiratory Drug Delivery

Cited by 67

A review of the adverse effects and safety of noradrenergic antidepressants

Whiskey, E., & Taylor, D. (2013) · Journal of Psychopharmacology

Treatment of Major DepressionNeurotransmitter Receptor Influence on Behavior

Cited by 64

Tapering antipsychotic treatment

Horowitz, M. A., Murray, R. M., & Taylor, D. (2021) · JAMA Psychiatry

Schizophrenia research and treatmentBipolar Disorder and Treatment

Cited by 49

Antidepressant withdrawal symptoms—Telephone calls to a national medication helpline

Taylor, D., Stewart, S., & Connolly, A. (2006) · Journal of Affective Disorders

Pharmacovigilance and Adverse Drug ReactionsTreatment of Major Depression

Cited by 37

How to reduce and stop psychiatric medication

Horowitz, M. A., & Taylor, D. (2022) · European Neuropsychopharmacology

Schizophrenia research and treatmentTreatment of Major Depression

Cited by 26

Estimating the optimal dose of flupentixol decanoate in the maintenance treatment of schizophrenia—a systematic review of the literature

Bailey, L., & Taylor, D. (2019) · Psychopharmacology

Schizophrenia research and treatmentTreatment of Major Depression

Cited by 21

Addiction and physical dependence are not the same thing

Horowitz, M. A., & Taylor, D. (2023) · The Lancet Psychiatry

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 16

Tapering of SSRI treatment to mitigate withdrawal symptoms—authors' reply

Horowitz, M. A., & Taylor, D. (2019) · The Lancet Psychiatry

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 15

Implementing gradual, hyperbolic tapering of long-acting injectable antipsychotics by prolonging the inter-dose interval: an in silico modelling study

O’Neill, J. R., Taylor, D. M., & Horowitz, M. A. (2023) · Therapeutic Advances in Psychopharmacology

Schizophrenia research and treatmentPharmaceutical studies and practices

Cited by 12

Using in silico methods to determine optimal tapering regimens for decanoate-based long-acting injectable psychosis drugs

O’Neill, J. R., Taylor, D. M., & Horowitz, M. A. (2024) · Therapeutic Advances in Psychopharmacology

Schizophrenia research and treatmentPharmacogenetics and Drug Metabolism

Cited by 7

Tapering and withdrawing opioids: guidance informed by fundamental principles to minimise withdrawal symptoms

Abie Horowitz, M., Framer, A., Strang, J., & Taylor, D. (2025) · Therapeutic Advances in Psychopharmacology

Opioid Use Disorder TreatmentPain Management and Opioid Use

Cited by 0

Pharmacological principles for safe benzodiazepine and Z-drug dose reduction

Horowitz, M., Lamberson, N., Brandt, J., Framer, A., Shapiro, B., Sørensen, A., Cadogan, C., Ritvo, A., & Taylor, D. (2026) · Psychological Medicine

Pharmaceutical Practices and Patient OutcomesSubstance Abuse Treatment and Outcomes

Cited by 0